Ginkgo Bioworks Holdings, Inc.DNANYSE
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +60.65% | +26.16% | +27.34% | -11.75% | -56.39% |
| Gross Profit Growth | +62.98% | +21.61% | +26.20% | -18.13% | -67.07% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +7.11% | +5.67% | +8.64% | +6.87% | +6.50% |
| Weighted Average Shares Diluted Growth | +7.13% | +4.90% | +8.50% | +6.78% | +6.48% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -62.08% | +25.39% | +10.63% | +22.42% | -10.49% |
| Inventory Growth | -100.00% | -100.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -26.92% | -17.29% | -18.23% | -24.26% | -19.70% |
| Book Value per Share Growth | -40.53% | -38.24% | -39.64% | -31.15% | -34.13% |
| Debt Growth | +10.39% | +95.45% | +85.32% | -5.18% | -5.10% |
| R&D Expense Growth | -50.85% | -34.74% | -48.03% | -60.24% | -9.94% |
| SG&A Expenses Growth | -36.25% | -35.78% | -30.22% | -34.71% | -14.03% |